Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZWINT | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZUFSP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | ZSWIM3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
mRNA | ZRANB3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | ZRANB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNFX1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF880 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ZNF862 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | ZNF707 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |